All In Biotech

Drug Trial Radar · NCT07361497

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Compared to Durvalumab in Participants With Unresectable Stage III NSCLC Without Progression After Platinum-based Concurrent Chemoradiation Therapy.

Last checked: Nov 20, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 850 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

850

Planned (sponsor's estimate)

Start

Mar 16, 2026

Primary completion

Sep 18, 2030

Study completion Jan 13, 2034

Sponsor

Lead sponsor
Bristol-Myers SquibbBristol Myers Squibb (BMY)
Sponsor type
Industry
Collaborators
BioNTech SE
First posted
Jan 23, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A study to evaluate Pumitamig versus Durvalumab following concurrent chemoradiation therapy in participants with unresectable stage III Non-small Cell Lung Cancer (NSCLC)

Conditions

  • Non-small Cell Lung Cancer (NSCLC)

Interventions

  • PumitamigDrug

    Specified dose on specified days

  • DurvalumabDrug

    Specified dose on specified days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression-free survival (PFS) by blinded independent central review (BICR) (per Response Evaluation Criteria in Solid Tumors (RECIST) v1.1)Time frame: Up to 3 years

Locations

259 sites in 32 countries. Site status is shown where the registry gives one.

  • Southern Cancer Center Pc

    Daphne, Alabama · Recruiting

  • Intermountain Health Cancer Center Lutheran Hospital

    Golden, Colorado · Recruiting

  • Medical Oncology Hematology Consultants, PA

    Newark, Delaware · Recruiting

  • Local Institution - 0711

    Ocala, Florida · Not yet recruiting

  • Florida Clinical Trials Group

    Tamarac, Florida · Recruiting

  • Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital

    Marietta, Georgia · Recruiting

  • University of Chicago Medical Center

    Chicago, Illinois · Recruiting

  • Endeavor Health

    Evanston, Illinois · Recruiting

  • Illinois Cancer Care

    Peoria, Illinois · Recruiting

  • Fort Wayne Medical Oncology and Hematology

    Fort Wayne, Indiana · Recruiting

  • University of Kentucky Chandler Medical Center

    Lexington, Kentucky · Recruiting

  • Local Institution - 0603

    Boston, Massachusetts · Not yet recruiting

  • Karmanos Cancer Institute

    Detroit, Michigan · Recruiting

  • Minnesota Oncology Hematology

    Maple Grove, Minnesota · Recruiting

  • Allina Health Cancer Institute - Abbott Northwestern Hospital

    Minneapolis, Minnesota · Recruiting

  • Missouri Cancer Associates

    Columbia, Missouri · Recruiting

  • Memorial Sloan Kettering Cancer Center

    New York, New York · Recruiting

  • Local Institution - 0339

    Westbury, New York · Withdrawn

  • Optum Medical Care, PC

    Westbury, New York · Recruiting

  • Novant Health Pharmacy Oncology Specialists

    Winston-Salem, North Carolina · Recruiting

  • Akron General Medical Center

    Akron, Ohio · Recruiting

  • The Christ Hospital

    Cincinnati, Ohio · Recruiting

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio · Recruiting

  • Cleveland Clinic

    Cleveland, Ohio · Recruiting

  • Cleveland Clinic - Hillcrest Hospital

    Mayfield Heights, Ohio · Recruiting

  • Oncology Associates Of Oregon, Pc

    Eugene, Oregon · Recruiting

  • Northwest Cancer Specialists, P.C.

    Happy Valley, Oregon · Recruiting

  • SCRI Oncology Partners

    Nashville, Tennessee · Recruiting

  • Tennessee Oncology

    Nashville, Tennessee · Recruiting

  • Texas Oncology - Amarillo Cancer Center

    Amarillo, Texas · Recruiting

  • Texas Oncology-Austin Central

    Austin, Texas · Recruiting

  • Texas Oncology

    Denton, Texas · Recruiting

  • The Center For Cancer And Blood Disorders

    Fort Worth, Texas · Recruiting

  • The University of Texas-MD Anderson Cancer Center

    Houston, Texas · Recruiting

  • Texas Oncology - San Antonio Medical Center

    San Antonio, Texas · Recruiting

  • Texas Oncology - Northeast Texas

    Tyler, Texas · Recruiting

  • Blue Ridge Cancer Care

    Christiansburg, Virginia · Recruiting

  • Virginia Oncology Associates

    Norfolk, Virginia · Recruiting

  • Instituto Medico Especializado Alexander Fleming

    Buenos Aires, Argentina · Recruiting

  • Clinica Adventista Belgrano

    Buenos Aires, Argentina · Recruiting

Showing 40 of 259 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.